Novira Therapeutics, Inc. Report issue

For profit Phase 1
Founded: Radnor PA United States (2009)
Status: Acquired by Johnson and Johnson (2015)

Organization Overview

First Clinical Trial
2014
NCT02112799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (2)

interferon alpha-2b (Intron-A) (2 trials)

nvr 3-778 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 1)

Hepatitis A (Phase 1)

Hepatitis B (Phase 1)

Hepatitis B, Chronic (Phase 1)

Hepatitis, Chronic (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2